Changes in access to health services during the COVID-19 pandemic: a scoping review
G Pujolar, A Oliver-Anglès, I Vargas… - International journal of …, 2022 - mdpi.com
The COVID-19 pandemic and the measures adopted are having a profound impact on a
major goal of public healthcare systems: universal access to health services. The objective …
major goal of public healthcare systems: universal access to health services. The objective …
A new emergency during the latest phase of the COVID-19 pandemic: access to healthcare services by patients with non-communicable diseases
C De Sarro, R Papadopoli, MC Morgante… - Frontiers in …, 2023 - frontiersin.org
Background The aim of our study was to investigate the impact of the COVID-19 pandemic
on the healthcare and the disease management of patients affected by non-communicable …
on the healthcare and the disease management of patients affected by non-communicable …
Outcome of emergency patients transported by ambulance during the COVID-19 pandemic in Osaka Prefecture, Japan: a population-based descriptive study
Y Katayama, K Tanaka, H Domi, J Masui… - Frontiers in Public …, 2024 - frontiersin.org
Background The novel corona virus (COVID-19) pandemic occurred worldwide. Although an
excessive burden was placed on emergency medical institutions treating urgent and severe …
excessive burden was placed on emergency medical institutions treating urgent and severe …
[HTML][HTML] Comparison of bleeding following gastrointestinal endoscopic biopsy in patients treated with and without direct oral anticoagulants
Background and study aims Despite the widespread use of direct oral anticoagulants
(DOACs), the association between DOAC use and complications (eg, bleeding) following …
(DOACs), the association between DOAC use and complications (eg, bleeding) following …
Effect of the COVID-19 pandemic on outpatient care and rehabilitation in neuromuscular clinical practice in Japan: a health insurance claims database analysis
T Saito, Y Matsuo-Tezuka, Y Sugitani, T Tajima… - BMJ open, 2023 - bmjopen.bmj.com
Objectives To evaluate the impact of the COVID-19 pandemic on outpatient care in
Japanese patients with neuromuscular diseases (NMDs). Design This retrospective cohort …
Japanese patients with neuromuscular diseases (NMDs). Design This retrospective cohort …
Comparative effectiveness of long-acting injectable antipsychotics in patients with schizophrenia in Japan
Y Okada, K Inada, M Akazawa - Schizophrenia Research, 2023 - Elsevier
Objective To compare the effectiveness of different long-acting injectable antipsychotics
(LAIs)(aripiprazole, paliperidone, risperidone, and fluphenazine/haloperidol) in patients with …
(LAIs)(aripiprazole, paliperidone, risperidone, and fluphenazine/haloperidol) in patients with …
Adherence of denosumab treatment for low bone mineral density in Japanese people living with HIV: a retrospective observational study
Y Kunimoto, R Matamura, H Ikeda, H Horiguchi… - … Health Care and …, 2023 - Springer
Background Long-term care issues, specifically metabolic bone disorders, are a concern for
people living with human immunodeficiency virus (PLWH) who undergo life-long …
people living with human immunodeficiency virus (PLWH) who undergo life-long …
Impact of the COVID-19 pandemic on utilization and cost for care of pediatric and young adult ALL
Objective Acute lymphoblastic leukemia (ALL) is the most common childhood malignancy
and among the most common malignancies in young adults and requires a unique pattern of …
and among the most common malignancies in young adults and requires a unique pattern of …
Alpha and Delta variants and vaccination effectiveness against severity in COVID-19 inpatients based on medical claims in Japan
S Mitsushima, H Horiguchi, K Taniguchi - GHM Open, 2023 - jstage.jst.go.jp
Some mutated strains of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
presumably have high infectivity and pathogenicity. Using Japanese medical claims data …
presumably have high infectivity and pathogenicity. Using Japanese medical claims data …
APOE-ε4 allele[s]-associated adverse events reported from placebo arm in clinical trials for Alzheimer's disease: implications for anti-amyloid beta therapy
APOE-ε4 allele [s] is a risk factor for Alzheimer's disease (AD) and Amyloid-Related Imaging
Abnormalities (ARIA) in anti-amyloid beta therapy, and is also associated with …
Abnormalities (ARIA) in anti-amyloid beta therapy, and is also associated with …